Desano Pharmaceutical

Desano Pharmaceutical, established in 1996, is a key player within the Pharmaceuticals and Healthcare sectors. Operating primarily as a B2B entity, the company focuses on the development and supply of critical pharmaceutical components. Its strategic positioning within China and the broader Asia-Pacific region underscores its commitment to serving global markets with specialized chemical and pharmaceutical innovations.

With a substantial workforce ranging from 1,000 - 5,000 employees, Desano Pharmaceutical demonstrates significant operational capacity. The company generates an annual revenue of $67.1M, reflecting its market penetration and product demand. Its primary offerings include Active Pharmaceutical Ingredients (APIs) and other pharmaceutical intermediates, crucial for drug manufacturing processes. Desano Pharmaceutical maintains a focused operational footprint, with its headquarters located in Zhangjiang, China, and a total of 1 location.

The company's technical expertise is further highlighted by its hashtags indicating a strong presence of scientists and engineering talent, supporting its innovation pipeline. Desano Pharmaceutical's business model is geared towards business-to-business transactions, supplying essential materials to other pharmaceutical manufacturers. For insights into the individuals driving these advancements, one can explore Meet Desano Pharmaceutical's team. This focus on specialized B2B pharmaceutical supply chains positions Desano Pharmaceutical as a vital contributor to the global healthcare ecosystem.